Our experience with the treatment of primary lymphomas of the central nervous system

Abstract

The aim of this study was to assess treatment efficiency overall survival (OS) and identify risk factors with the influence on patients prognosis in patients with primary central nervous system lymphomas who were treated with intensive chemotherapy based on high-dose methotrexate and cytosin-arabinoside followed by whole-brain radiotherapy (MPV regimen).

Keywords

• Primary central nervous system lymphoma
• chemotherapy
• radiotherapy
• methotrexate
• risk factors
• Overall survival